A novel mechanism used by pathogenic mycobacteria to enter macrophages (in low complement environments) may provide a new therapeutic target for the treatment of tuberculosis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Schlesinger, L.S. & Horwitz, M.A. Phagocytosis of Mycobacterium leprae by human monocyte-derived macrophages is mediated by complement receptors CR1 (CD35), CR3 (CD11 b/CDI 8), and CR4 (CD11C/CD18) and IFN-γ activation inhibits complement receptor function and phagocytosis of this bacterium. J. Immunol. 147, 1983–1994 (1991).
Schorey, J.S., Carroll, M.C. & Brown, E.J. A macrophage invasion mechanism of pathogenic mycobacteria. Science 277, 1091–1093 (1997).
Cole, F.S., Mattews, W.J., Marino, J.T., Gash, D.J. & Colten, H.R. Control of complement synthesis and secretion in bronchoalveolar and peritoneal macrophages. J. Immunol. 125, 1120–1124 (1980).
Sai-Baba, K.S., Moudgil, K.D., Jain, R.C. & Srivastava, L.M. Complement activation in pulmonary tuberculosis. Tubercle 71, 103–107 (1990).
Schlesinger, L.S. Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors. J. Immunol. 150, 2920–2930 (1993).
Gaynor, C.D., McCormack, F.X., Voelker, D.R., McGowan, S.E. & Schlesinger, L.S. Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobecterium tuberculosis by a direct interaction with human macrophages. J. Immunol. 155, 5343–5351 (1995).
Downing, J.F., Pasula, R., Wright, J.R., Twigg, H.L. & Martin, W.J. Surfactant protein A promotes attachment of Mycobacterium tuberculosis to alveolar macrophages during infection with human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 92, 4848–4852 (1995).
Cywes, C. et al. Nonopsonic binding of Mycobacterium tuberculosis to human complement receptor type 3 expressed in Chinese hamster ovary cells. Infect. Immun. 64, 537–35383 (1996).
Arruda, S., Bomfim, G., Knights, R., Huima-Byron, T. & Riley, L.W. Cloning of an M. tuberculosis DNA fragment associated with entry and survival inside cells. Science 261, 1454–1457 (1993).
Menozzi, F.D. et al. Identification of a heparin binding hemagglutinin present in mycobacteria. J. Exp. Med. 184, 993–1001 (1996).
Shiratsuchi, H. Johnson, J.L. & Ellner, J.J. Bidirectional effects of cytokines on the growth of Mycobacterium avium within human monocytes. J. Immunol. 146, 3165–3170 (1991).
Dahl, K.E., Shiratsuchi, H., Hamilton, B.D. & Toossi, Z. Selective induction of transforming growth factor β in human monocytes by lipoarabinomannan of Mycobacterium tuberculosis. Infect. Immun. 64, 399–405 (1996).
Aung, H. et al. Induction of monocyte expression of tumor necrosis factor α by the 30 kDa antigen of Mycobacterium tuberculosis and synergism with fibronectin. J. Clin. Invest. 98, 1261–1268 (1996).
Hirsch, C.S. et al. Cross-modulation by transforming growth factor β in human tuberculosis: suppression of antigen-driven blastogenesis and interferon g production. Proc. Natl. Acad. Sci. USA 93, 3193–3198 (1996).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zaffran, Y., Ellner, J. A coat of many complements. Nat Med 3, 1078–1079 (1997). https://doi.org/10.1038/nm1097-1078
Issue Date:
DOI: https://doi.org/10.1038/nm1097-1078